11.00 Translating Successful Learnings from J-Brain Cargo® to Innovate Second Generation Antibodies with Enhanced BBB Penetration in Other CNS Indications

Time: 11:00 am
day: Day One Track 1 AM

Details:

  • Outlining rationale for successful development of an antibody shuttle platform to increase brain uptake while managing risks of anaemia
  • Applying transferrin-mediated transcytosis technology to optimize delivery of biologics to treat neurodegeneration, neuroinflammation, and more

Speakers: